Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 21,948 shares at $35.02 ($769K) on 2023-11-24, disclosed to the SEC on 2023-11-28.
Open-market sale of $769k RYTM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.02 | 10,974 | $384K | 50.0% |
| 2 | $35.02 | 10,974 | $384K | 50.0% |
| Total | $35.02 avg | 21,948 | $769K | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |